Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Chemother ; 10(2): 132-5, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9603639

ABSTRACT

We describe a case of a 25-year-old female with an acute left otomastoiditis, accompanied by a left temporal extradural abscess with moderate perifocal edema and meningitis. Intravenous meropenem (2 g 8-hourly) and intravenous methylprednisolone (40 mg once daily) were commenced empirically. Teicoplanin (400 mg once daily intravenously) was added after 5 days when culture results were available. Teicoplanin was discontinued on day 25 but meropenem and methylprednisolone were continued for a further 15 days, after which the abscess completely resolved without sequelae. No treatment-induced adverse effects or seizures were observed. Thus, in selected patients, antibacterials (in conjunction with a corticosteroid) may be successfully used without surgery to treat brain abscesses and in such circumstances meropenem is a useful option for empiric therapy.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Brain Abscess/drug therapy , Drug Therapy, Combination/therapeutic use , Mastoiditis/complications , Meningitis/drug therapy , Thienamycins/therapeutic use , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Brain Abscess/diagnostic imaging , Brain Abscess/etiology , Brain Edema/diagnostic imaging , Brain Edema/drug therapy , Brain Edema/etiology , Drug Therapy, Combination/administration & dosage , Female , Humans , Injections, Intravenous , Meningitis/diagnostic imaging , Meningitis/etiology , Meropenem , Methylprednisolone/administration & dosage , Methylprednisolone/therapeutic use , Teicoplanin/administration & dosage , Teicoplanin/therapeutic use , Thienamycins/administration & dosage , Tomography, X-Ray Computed
2.
Riv Eur Sci Med Farmacol ; 18(4): 163-7, 1996.
Article in English | MEDLINE | ID: mdl-9177616

ABSTRACT

The authors valued the incidence and clinical therapeutic aspects of Haemophilus influenzae type b (Hib) meningitis in children. They report a retrospective study, in children, with diagnosis of acute purulent meningitis, from January 1982 to December 1994, aged between 1 month and 14 years. Particular attention was direct to Haemophilus influenzae type b meningitis (20 cases). The incidence rate of Hib meningitis in the overall cases (89) was 22.47% (20), while among children younger than 5 years Hib was the most frequently pathogen isolated (20/58-34.47%). In 1/4 of cases, particularly in children younger than 1 years, exordium was aspecific and unclear. At admission culture and examination of Cerebrospinal Fluid (CFS) have been done. CFS was cultured on blood agar and chocolate plates. A latex agglutination test was used for rapid detection of the bacterial antigens. In some cases we looked for bacterial antigens in urine. 20% of children had complications and 10% had sequelae (1 years of follow-up). We didn't have any dead. Antibiotic treatment was principally with Ampicillin, Cephalosporin and Chloramphenicol. The results of this study confirm the Hib gravity and suggest that the administration of conjugate vaccine against Hib to all living in Italy is justified.


Subject(s)
Haemophilus influenzae , Meningitis, Haemophilus/microbiology , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Meningitis, Haemophilus/pathology , Meningitis, Haemophilus/physiopathology , Retrospective Studies
3.
Minerva Pediatr ; 46(4): 181-3, 1994 Apr.
Article in Italian | MEDLINE | ID: mdl-8084327

ABSTRACT

The authors report their experience on the use of oral suspension of Clarithromycin in respiratory infections in the pediatric age. Thirty-three patients affected by various infectious pathologies of the respiratory tract, treated with oral Clarithromycin at the dosage of 15 mg/kg/day, were studied. The therapeutic outcome was very encouraging, the drug well tolerated and without side effects.


Subject(s)
Clarithromycin/therapeutic use , Respiratory Tract Diseases/drug therapy , Administration, Oral , Child , Child, Preschool , Clarithromycin/administration & dosage , Humans , Infant , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...